No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs184495221 |
chr6:29815549-29815550 |
Inactive region
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs28993600 |
chr6:29815550-29815551 |
Inactive region
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs3094179 |
chr6:29815571-29815572 |
Inactive region
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs112461612 |
chr6:29815576-29815577 |
Inactive region
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs556579654 |
chr6:29815597-29815598 |
Inactive region
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs28721723 |
chr6:29815607-29815608 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs73747723 |
chr6:29815609-29815610 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs374092457 |
chr6:29815636-29815637 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs3128912 |
chr6:29815637-29815638 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
10 |
rs28721736 |
chr6:29815638-29815639 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs559820319 |
chr6:29815694-29815695 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs564086292 |
chr6:29815704-29815705 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs3115629 |
chr6:29815713-29815714 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
14 |
rs6902658 |
chr6:29815732-29815733 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs6922605 |
chr6:29815744-29815745 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
16 |
rs9258566 |
chr6:29815754-29815755 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs376338223 |
chr6:29815772-29815773 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs6922901 |
chr6:29815787-29815788 |
Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs568641358 |
chr6:29815803-29815804 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs527925968 |
chr6:29815806-29815807 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs28721806 |
chr6:29815841-29815842 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs571193782 |
chr6:29815872-29815873 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs540114116 |
chr6:29815903-29815904 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs115047626 |
chr6:29815963-29815964 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs561589704 |
chr6:29815964-29815965 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs569918628 |
chr6:29815971-29815972 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs2894118 |
chr6:29815984-29815985 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs28743472 |
chr6:29815992-29815993 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs140232309 |
chr6:29815999-29816000 |
Weak transcription Bivalent Enhancer Bivalent/Poised TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs28743475 |
chr6:29816003-29816004 |
Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs2394183 |
chr6:29816010-29816011 |
Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
32 |
rs6923284 |
chr6:29816034-29816035 |
Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
33 |
rs28743497 |
chr6:29816095-29816096 |
Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs573509702 |
chr6:29816122-29816123 |
Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs150953661 |
chr6:29816140-29816141 |
Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs527953228 |
chr6:29816201-29816202 |
Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs528171633 |
chr6:29816243-29816244 |
Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs2394184 |
chr6:29816282-29816283 |
Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs62392521 |
chr6:29816289-29816290 |
Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
40 |
rs28743576 |
chr6:29816310-29816311 |
Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs558899043 |
chr6:29816349-29816350 |
Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs2394185 |
chr6:29816371-29816372 |
Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
43 |
rs2394186 |
chr6:29816421-29816422 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs528947540 |
chr6:29816450-29816451 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs28743648 |
chr6:29816495-29816496 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs566077716 |
chr6:29816496-29816497 |
Enhancers Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|